xGen™ SARS-CoV-2 Amp Panel 96rxn
Integrated DNA Technologies Inc.COVID panels that utilize multiple overlapping amplicons in a single tube, comprises a premixed target-specific primer pool.
COVID panels that utilize multiple overlapping amplicons in a single tube, comprises a premixed target-specific primer pool.
COVID panels that utilize multiple overlapping amplicons in a single tube, comprises a premixed target-specific primer pool.
COVID panels that utilize multiple overlapping amplicons in a single tube, comprises a premixed target-specific primer pool.
Targeted amplicon library prep kit for contiguous coverage (overlapping amplicons), comprises multiplexed PCR, indexing PCR, and Normalase™ reagents (target-specific panel and indexing primers sold separately).
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Oncology and infectious disease panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Metagenomics panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
Metagenomics panels that utilize multiple overlapping amplicons in a single tube; comprises a premixed target-specific primer pool.
EGFR amplicon panel utilizing UMIs for identification of mutations occurring at 0.25% allele frequency. Custom panels available upon request.
Tailored to meet your research needs, custom amplicon panels offer a completely curated targeted sequencing workflow to interrogate genomic targets relevant to you.
Monkeypox Virus panel that utilizes multiple overlapping amplicons in a single tube, comprises a premixed target-specific primer pool.
GEM-X Flex Gene Expression with Feature Barcode technology Single cell RNA sequencing is increasingly being used to profile larger numbers of patient cohorts or different perturbations, making an efficient and scalable workflow paramount.
Digital DNA sequencing to confidently detect low-frequency variants
An expanding portfolio of NGS panels for research into haematological and solid tumour cancers, as well as library preparation kits for the accurate detection of a wide range of genetic aberrations
The SureSeq™ Myeloid Plus NGS Complete Workflow combines the rapid Universal NGS Workflow hybridisation-based target enrichment method together with OGT’s expert bait design to detect 49 key genes implicated in myeloid disorders.
The SureSeq™ CLL + CNV Panel has been designed in collaboration with recognised cancer experts to detect 13 key genes and 5 chromosomal regions implicated in CLL progression (Table 1). The SureSeq CLL + CNV Panel alleviates the burden of running multiple assays and streamlines your CLL research to deliver a comprehensive genomic profile for each CLL sample using a single workflow